Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 2011. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific share transaction notification and does not contain financial statements or performance metrics.
Material Changes
The filing details a specific transaction on October 6, 2011, where Mrs. K Thomson (a connected person to Director Mr. P C Thomson) acquired 9 Ordinary shares. The acquisition occurred at a price of 1350.46 pence per share through the Company's Share Reward Plan, specifically under the Dividend Reinvestment element.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of a connected person's share acquisition.
Investor Verification Checklist
- Verify the total shareholding of Mrs. K Thomson following the acquisition of 9 shares.
- Confirm the terms of the Company's Share Reward Plan and Dividend Reinvestment element.
- Review the price of 1350.46 pence per share against the market price on October 6, 2011.
- Check for any other concurrent transactions by connected persons not detailed in this specific notification.